BTG News

8,111 +0,26% +0,021 €
08:04 Uhr Frankfurt | Orderbuch | Mehr Kurse »
WKN: 908827
ISIN: GB0001001592
US-Symbol: BTGGF
Typ: Aktie

BTG News

16.11.17 New Consensus Guidelines Provide Specific Recommendations for Use of Voraxaze® in Patients with Delayed Methotrexate Clearance PR Newswire
16.11.17 New Consensus Guidelines Provide Specific Recommendations for Use of Voraxaze® in Patients with Delayed Methotrexate Clearance PR Newswire
09.10.17 First Patient Treated With Microscopic Beads Pre-​loaded With a Targeted Cancer Drug and Visible on CT Scans PR Newswire
09.10.17 First Patient Treated With Microscopic Beads Pre-​loaded With a Targeted Cancer Drug and Visible on CT Scans PR Newswire
13.09.17 Vistogard® and Voraxaze® Added to Revised Guidelines for Stocking of Antidotes in US Hospitals PR Newswire
13.09.17 Vistogard® and Voraxaze® Added to Revised Guidelines for Stocking of Antidotes in US Hospitals PR Newswire
21.08.17 BTG and SIO Expand Immuno-​Oncology / Interventional Oncology Grant Programme PR Newswire
21.08.17 BTG and SIO Expand Immuno-​Oncology / Interventional Oncology Grant Programme PR Newswire
13.06.17 New Study Shows Patients Treated With CroFab® Have Improved Recovery From Copperhead Envenomation PR Newswire
13.06.17 New Study Shows Patients Treated With CroFab® Have Improved Recovery From Copperhead Envenomation PR Newswire
10.06.17 New Study Shows IO Loop™ Improves Patient Follow-up, Engagement and Satisfaction Following Treatment With TheraSphere® PR Newswire
10.06.17 New Study Shows IO Loop™ Improves Patient Follow-up, Engagement and Satisfaction Following Treatment With TheraSphere® PR Newswire
07.06.17 SIO Announces First Grants in Interventional Oncology / Immuno-​Oncology Research Programme PR Newswire
07.06.17 SIO Announces First Grants in Interventional Oncology / Immuno-​Oncology Research Programme PR Newswire
19.05.17 BTG and HealthLoop Collaborate on IO Loop™, an Exclusive Service to Connect Patients and Interventional Oncologists Throughout Treatment PR Newswire
20.04.17 First European Patients Treated With DC Bead LUMI™ Radiopaque Drug-​Eluting Beads PR Newswire
20.04.17 First European Patients Treated With DC Bead LUMI™ Radiopaque Drug-​Eluting Beads PR Newswire
07.03.17 BTG gibt CE-​Kennzeichnung für DC Bead LUMI™ bekannt, die ersten in der EU im Handel erhältlichen radioopaken Drug-​Eluting Beads PR Newswire
07.03.17 BTG Announces CE Mark Certification for DC Bead LUMI™, the First Commercially Available Radiopaque Drug-​Eluting Bead in the EU PR Newswire
15.02.17 BTG and Society of Interventional Oncology to Explore Role of Minimally Invasive Therapies in Immuno-​oncology PR Newswire
15.02.17 BTG and Society of Interventional Oncology to Explore Role of Minimally Invasive Therapies in Immuno-​oncology PR Newswire
05.12.16 PneumRx® Coils Included in New Global Clinical Guidelines and Given Positive Recommendation to Treat Severe Emphysema Patients in France PR Newswire
05.12.16 PneumRx® Coils Included in New Global Clinical Guidelines and Given Positive Recommendation to Treat Severe Emphysema Patients in France PR Newswire
19.10.16 First Patient in Malaysia Receives TheraSphere™ radioembolisation Therapy PR Newswire
19.10.16 First Patient in Malaysia Receives TheraSphere™ radioembolisation Therapy PR Newswire
14.10.16 BTG and Mirada Medical Announce CE Mark Certification for Simplicit90Y™ Dosimetry Software in Europe PR Newswire
14.10.16 BTG and Mirada Medical Announce CE Mark Certification for Simplicit90Y™ Dosimetry Software in Europe PR Newswire
09.09.16 BTG Launches βETA™ Radiation Safety Programme, to Reduce the Risk of Radiation Exposure for Healthcare Professionals and Patients PR Newswire
09.09.16 BTG Launches βETA™ Radiation Safety Programme, to Reduce the Risk of Radiation Exposure for Healthcare Professionals and Patients PR Newswire
17.08.16 CMS Grants Vistogard® New Technology Add-on Payment Status Effective 1 October 2016 PR Newswire
02.08.16 BTG Announces Successful CE Mark Reclassification for DC Bead® to Class III Based on its Ability to Administer Medicines PR Newswire
02.08.16 BTG Announces Successful CE Mark Reclassification for DC Bead® to Class III Based on its Ability to Administer Medicines PR Newswire
26.05.16 New Study Highlights Potential Cost Savings When Using Yttrium-90 Glass Microspheres for Treatment of Hepatocellular Carcinoma PR Newswire
26.05.16 New Study Highlights Potential Cost Savings When Using Yttrium-90 Glass Microspheres for Treatment of Hepatocellular Carcinoma PR Newswire
02.04.16 BTG to Initiate Multi-​Centre TARGET Study Evaluating Dosimetry for 90Y Radioembolisation Therapy in Patients With Hepatocellular Carcinoma PR Newswire
02.04.16 BTG to Initiate Multi-​Centre TARGET Study Evaluating Dosimetry for 90Y Radioembolisation Therapy in Patients With Hepatocellular Carcinoma PR Newswire
01.04.16 BTG Announces US Launch of LC Bead LUMI™, Ground-​Breaking Radiopaque Embolic Bead PR Newswire
26.01.16 First Patients in South Korea Receive TheraSphere® Radioembolisation Treatment PR Newswire
14.12.15 BTG Announces FDA Clearance for LC Bead LUMI™, the First Commercially Available Radiopaque Embolic Bead in the US PR Newswire
12.10.15 BTG and MIRADA Collaborate to Develop Dosimetry Software Solutions to Optimise Radioembolisation Therapy in Interventional Oncology PR Newswire
12.10.15 BTG and MIRADA Collaborate to Develop Dosimetry Software Solutions to Optimise Radioembolisation Therapy in Interventional Oncology PR Newswire
12.10.15 BTG und MIRADA arbeiten gemeinsam an der Entwicklung von Dosimetrie-​Softwarelösungen zur Optimierung der Radioembolisationtherapie in der interventionellen Onkologie PR Newswire
06.08.15 Health Canada Approves Varithena™ (polidocanol injectable foam) for Patients With Varicose Veins PR Newswire
26.11.13 BTG plc: FDA Approves Varithena™ (Polidocanol Injectable Foam) for the Treatment of Patients with Varicose Veins PR Newswire
23.10.13 ROUNDUP: JPMorgan droht weitere Milliardenforderung in Hypothekenstreit dpa-AFX
30.07.13 TheraSphere® Recommended by the National Institute for Health and Care Excellence (NICE) for the Treatment of Primary and Secondary Liver Cancer PR Newswire
14.12.12 BTG-Aktie: "buy" - Deutsche Bank Aktiencheck
19.11.12 BTG-Aktie: "buy" - Deutsche Bank Aktiencheck
09.11.06 BTG PLC (UK) - BTG - interim results presentation Hugin

Newssuche

Videos

15:52 Uhr
Börsenpunk: Shopping-​Wahnsinn, Tinderellas, Chinaknaller - diese Aktien sorgen für Furore